An Overview of Maxzide and Pregnancy
Maxzide® (
triamterene-HCTZ) is a pregnancy Category C medicine, meaning that it could potentially cause harm to your unborn child.
Maxzide and Pregnancy Category C
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that show side effects to the fetus in animal studies but on which no human studies in pregnant women have been done. Pregnancy Category C is also given to medicines that have not been studied in either pregnant women or animals. A pregnancy Category C medicine may still be given to a pregnant woman if the healthcare provider believes that the benefits to the mother outweigh the possible risks to the unborn child.
Maxzide has not been studied in pregnant animals or humans. However, similar medications have not caused problems in pregnant animals. Despite this, it is important to note that animals do not always respond to medicines in the same way that humans do. Therefore, Maxzide may be given to a pregnant woman if the benefits outweigh the possible risks. Generally, Maxzide should be used in pregnant women only when absolutely necessary, and the medication should not be used to treat
high blood pressure during pregnancy.
Final Thoughts on Maxzide and Pregnancy
If you are taking Maxzide and pregnancy occurs (or you are thinking of becoming pregnant), let your healthcare provider know.
He or she will consider both the benefits and risks of taking the drug during pregnancy before making a recommendation for your particular situation.
Add this article to your Favorites
Email this article
Print